1. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone
- Author
-
Di Gregorio, Gina B., Yao-Borengasser, Aiwei, Rasouli, Neda, Varma, Vijayalakshmi, Lu, Tong, Miles, Leslie M., Ranganathan, Gouri, Peterson, Charlotte A., McGehee, Robert E., and Kern, Philip A.
- Subjects
Cytokines -- Research -- Genetic aspects ,Diabetes -- Genetic aspects -- Research ,Insulin resistance -- Research -- Genetic aspects ,Health ,Genetic aspects ,Research - Abstract
To examine the role of adipose-resident macrophages in insulin resistance, we examined the gene expression of CD68, a macrophage marker, along with macrophage chemoattractant protein-1 (MCP-1) in human subcutaneous adipose tissue using real-time RT-PCR. Both CD68 and MCP-1 mRNAs were expressed in human adipose tissue, primarily in the stromal vascular fraction. When measured in the adipose tissue from subjects with normal glucose tolerance, covering a wide range of BMI (21-51 kg/[m.sup.2]) and insulin sensitivity ([S.sub.I]) (0.6-8.0 x [10.sup.-4] [min.sup.-1] x µ[U.sup.-1] x [ml.sup.-1]), CD68 mRNA abundance, which correlated with the number of CD68-positive cells by immunohistochemistry, tended to increase with BMI but was not statistically significant. However, there was a significant inverse relation between CD68 mRNA and SI (r = -0.55, P = 0.02). In addition, there was a strong positive relationship among adipose tissue CD68 mRNA, tumor necrosis factor-a (TNF-α) secretion in vitro (r = 0.79, P < 0.005), and plasma interleukin-6 (r = 0.67, P < 0.005). To determine whether improving [S.sub.I] in subjects with impaired glucose tolerance (IGT) was associated with decreased CD68 expression, IGT subjects were treated for 10 weeks with pioglitazone or metformin. Pioglitazone increased [S.sub.I] by 60% and in the same subjects reduced both CD68 and MCP-1 mRNAs by >50%. Furthermore, pioglitazone resulted in a reduction in the number of CD68-positive cells in adipose tissue and reduced plasma TNF-α. Metformin had no effect on any of these measures. Thus, treatment with pioglitazone reduces expression of CD68 and MCP-1 in adipose tissue, apparently by reducing macrophage numbers, resulting in reduced inflammatory cytokine production and improvement in [S.sub.I]., The increasing prevalence of obesity over the last few decades has been associated with a parallel increase in diabetes and metabolic syndrome (1-3). Although there is a significant correlation between [...]
- Published
- 2005